Disclosures for "An Experience of a Single Comprehensive Stroke Center after Implementation of Routine Tenecteplase Administration for Acute Ischemic Stroke Treatment. ")
-
Dr. Cawley has nothing to disclose.
-
Dr. Simon has nothing to disclose.
-
Dr. Radomski has nothing to disclose.
-
Dr. Kuns has nothing to disclose.
-
Dr. Bejleri has nothing to disclose.
-
Dr. Seol has nothing to disclose.
-
Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.